Clinical trial
A Prospective Phase II Open-Label Pilot Study Evaluating the Efficacy and Safety of Methotrexate in the Treatment of Severe Vulvar Lichen Sclerosus
NCT07352917 is registered in ClinicalTrials.gov with Clinica Dermatologica Arbache ltda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Phase II Open-Label Pilot Study Evaluating the Efficacy and Safety of Methotrexate in the Treatment of Severe Vulvar Lichen Sclerosus
- Lead sponsor
- Clinica Dermatologica Arbache ltda
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 21, 2026
- Completion date
- January 31, 2027
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.